{"id":"allogeneic-transfusion","safety":{"commonSideEffects":[{"rate":"null","effect":"Acute hemolysis"},{"rate":"null","effect":"Graft-versus-host disease"},{"rate":"null","effect":"Transfusion-related acute lung injury"}]},"_chembl":{"chemblId":"CHEMBL5315108","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This process can help increase red blood cell count, improve oxygen delivery to tissues, and support the recipient's overall health. Allogeneic transfusion can be used to treat a variety of conditions, including anemia, bleeding disorders, and blood cancers.","oneSentence":"Allogeneic transfusion involves the transfer of blood components from a donor to a recipient to replace or supplement the recipient's blood supply.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:21:38.421Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of anemia in patients with chronic kidney disease"},{"name":"Treatment of bleeding disorders, such as hemophilia A and B"}]},"trialDetails":[{"nctId":"NCT03910452","phase":"EARLY_PHASE1","title":"Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-10-28","conditions":"Chronic Granulomatous Disease","enrollment":4},{"nctId":"NCT05889494","phase":"NA","title":"Autologous Whole Blood Management for Transfusion Reduction in Adult Cardiac Surgery Patients","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2025-03-24","conditions":"Postoperative Hemorrhage, Postoperative Anemia, Postoperative Blood Loss","enrollment":64},{"nctId":"NCT06872333","phase":"PHASE2","title":"Allo HSCT for High Risk Hemoglobinopathies","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2024-11-19","conditions":"Graft Failure, Sickle Cell Disease, Hemoglobinopathies","enrollment":62},{"nctId":"NCT05736419","phase":"PHASE2","title":"A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-02-09","conditions":"Sickle Cell Disease, Thalassemia, Beta, Thalassemia","enrollment":24},{"nctId":"NCT07441720","phase":"PHASE2","title":"Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)","status":"RECRUITING","sponsor":"Zhejiang Cancer Hospital","startDate":"2026-02-28","conditions":"Thrombocytopenia, Cancer Treatment-induced Thrombocytopenia","enrollment":25},{"nctId":"NCT07321626","phase":"PHASE1","title":"Romiplostim N01 for Platelet Recovery After Haploidentical HSCT","status":"RECRUITING","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2025-06-01","conditions":"Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome), Delayed Platelet Engraftment","enrollment":130},{"nctId":"NCT06147531","phase":"PHASE2","title":"Delayed Cold-Stored Platelets -PLTS-1","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2024-06-05","conditions":"Platelets, Bleeding, Cardiopulmonary Bypass","enrollment":150},{"nctId":"NCT01962415","phase":"PHASE2","title":"Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT","status":"RECRUITING","sponsor":"Paul Szabolcs","startDate":"2014-02-04","conditions":"Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes, Inherited Metabolic Disorders (IMD)","enrollment":100},{"nctId":"NCT04922307","phase":"NA","title":"Reduction of Allogenic Blood Transfusion in Locally Advanced Kidney Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2021-07-23","conditions":"Kidney Cancer","enrollment":240},{"nctId":"NCT02684474","phase":"","title":"Expanded Access Protocol Using HBOC-201","status":"NO_LONGER_AVAILABLE","sponsor":"Johns Hopkins University","startDate":"","conditions":"Anemia","enrollment":""},{"nctId":"NCT03459287","phase":"PHASE3","title":"Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients","status":"COMPLETED","sponsor":"Cerus Corporation","startDate":"2018-12-05","conditions":"Anemia","enrollment":581},{"nctId":"NCT07152379","phase":"PHASE2","title":"Challenge Transfusion of INTERCEPT Pathogen Reduced Red Blood Cells (RBCs) in Subjects With or Without Pre-existing Antibodies to INTERCEPT RBCs","status":"NOT_YET_RECRUITING","sponsor":"Cerus Corporation","startDate":"2026-01-01","conditions":"Transfusion Reaction, Hemolytic","enrollment":10},{"nctId":"NCT07125612","phase":"","title":"Impact of Perioperative Allogeneic Red Blood Cell Transfusion on Postoperative Myocardial Injury After Liver Resection","status":"COMPLETED","sponsor":"Hao Li","startDate":"2016-01-01","conditions":"Myocardial Injury, Acuter Kidney Injury","enrollment":487},{"nctId":"NCT07064954","phase":"PHASE2, PHASE3","title":"Autologous Cold-stored Apheresis Platelets","status":"NOT_YET_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-09-01","conditions":"Bleeding, Platelets, Cardiopulmonary Bypass","enrollment":100},{"nctId":"NCT03429790","phase":"NA","title":"Cell Salvage During Caesarean Section (CSCS)","status":"WITHDRAWN","sponsor":"Wenzhou Medical University","startDate":"2018-11-01","conditions":"Blood Transfusion","enrollment":""},{"nctId":"NCT06240117","phase":"NA","title":"Impact of Intraoperative Cell Salvage","status":"TERMINATED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2024-03-11","conditions":"Peripartum Anemia","enrollment":20},{"nctId":"NCT07029958","phase":"PHASE4","title":"Improved Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Protocol for the Treatment of Epstein Barr Virus T/NK Lymphoproliferative Disease (EBV-T/NK LPD) and Prevention of Post Transplant Graft-versus-host Disease","status":"RECRUITING","sponsor":"Beijing Children's Hospital","startDate":"2024-11-12","conditions":"EBV-T/NK LPD","enrollment":48},{"nctId":"NCT07021534","phase":"PHASE1","title":"Hepatic Artery Transfusion of NKG2D CAR-NK Cells Followed by Intravenous Infusion of NKG2D CAR-T Cells to Treat Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments: a Phase I Exploratory Clinical Trial","status":"RECRUITING","sponsor":"Zhejiang University","startDate":"2025-06-10","conditions":"Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments","enrollment":12},{"nctId":"NCT06956469","phase":"NA","title":"BmemHLA : Origins of the Heterogeneity of the Anti-HLA Memory B Cells in Kidney Transplantation","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Bordeaux","startDate":"2025-06-15","conditions":"Kidney Transplantation, Immunology","enrollment":75},{"nctId":"NCT01350232","phase":"NA","title":"Treatment of Sickle Cell Anemia With Stem Cell Transplant","status":"TERMINATED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","startDate":"2009-09","conditions":"Sickle Cell Anemia, Sickle Cell-hemoglobin C Disease, Sickle Cell-β0-thalassemia","enrollment":2},{"nctId":"NCT03186456","phase":"PHASE1","title":"The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Cerebral Infarction","enrollment":40},{"nctId":"NCT03180450","phase":"PHASE1, PHASE2","title":"The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-HF)","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Heart Failure","enrollment":60},{"nctId":"NCT06968936","phase":"NA","title":"Perioperative Blood Conservation: Role of Combined Iron Supplementation Protocols in Reducing Allogeneic Transfusion","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-05-15","conditions":"Anemia, Iron Deficiencies, Cardiac Surgery","enrollment":400},{"nctId":"NCT02314988","phase":"PHASE2, PHASE3","title":"Tranexamic Acid to Reduce Blood Loss in Spine Surgery","status":"RECRUITING","sponsor":"Columbia University","startDate":"2020-06-15","conditions":"Spinal Injuries, Spinal Deformity","enrollment":252},{"nctId":"NCT06553833","phase":"","title":"Outcomes of Patient Blood Management in Patients Undergoing Major Surgery","status":"COMPLETED","sponsor":"Helios Klinik Gotha/Ohrdruf","startDate":"2024-09-01","conditions":"Major Surgery","enrollment":25979},{"nctId":"NCT06012760","phase":"NA","title":"The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-01-04","conditions":"Anemia, Iron Deficiency Anemia, Perioperative","enrollment":400},{"nctId":"NCT01499888","phase":"PHASE1, PHASE2","title":"Ph I/II Study of Allogeneic SCT for Clinically Aggressive Sickle Cell Disease (SCD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2011-11-11","conditions":"Sickle Cell Disease","enrollment":45},{"nctId":"NCT06886919","phase":"EARLY_PHASE1","title":"Clinical Study Evaluating the Safety and Efficacy of IC19 CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus","status":"NOT_YET_RECRUITING","sponsor":"Beijing Immunochina Medical Science & Technology Co., Ltd.","startDate":"2025-03-31","conditions":"Difficult to Treat Systemic Lupus Erythematosus","enrollment":6},{"nctId":"NCT06459141","phase":"NA","title":"The Effect of Acute Normovolemic Hemodilution in Bone Tumor Surgery","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2024-06-07","conditions":"Acute Normovolemic Hemodilution, Bone Tumor, Goal-Directed Fluid Therapy","enrollment":150},{"nctId":"NCT02179359","phase":"NA","title":"Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2014-09-02","conditions":"Sickle Cell Disease, Transfusion Dependent Alpha- or Beta- Thalassemia, Diamond Blackfan Anemia","enrollment":38},{"nctId":"NCT03633604","phase":"","title":"Expanded Access IND Administration of HBOC-201 in Patients With Severe Acute Anemia","status":"AVAILABLE","sponsor":"Jonathan H. Waters","startDate":"","conditions":"Anemia Severe","enrollment":""},{"nctId":"NCT02986698","phase":"PHASE1","title":"In Utero Hematopoietic Stem Cell Transplantation for Alpha-thalassemia Major (ATM)","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2017-10-05","conditions":"Alpha Thalassemia Major, Hemoglobinopathy; with Thalassemia, Hemoglobinopathies","enrollment":6},{"nctId":"NCT02934282","phase":"","title":"HBOC-201 Expanded Access Protocol for Life-threatening Anemia for Whom Allogeneic Blood Transfusion is Not an Option","status":"NO_LONGER_AVAILABLE","sponsor":"Mauricio Lynn","startDate":"","conditions":"Anemia","enrollment":""},{"nctId":"NCT06399536","phase":"NA","title":"Individualized ANH for Non-cardiac Surgery","status":"RECRUITING","sponsor":"West China Hospital","startDate":"2024-06-01","conditions":"Transfusion Related Complication, Hemodilution","enrollment":40},{"nctId":"NCT03204357","phase":"NA","title":"Fresh Autologous Whole Blood Transfusion After Cardiopulmonary Bypass","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2022-01-24","conditions":"Cardiac Disease, Bleeding Postoperative","enrollment":70},{"nctId":"NCT01019876","phase":"PHASE2, PHASE3","title":"Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases","status":"COMPLETED","sponsor":"Columbia University","startDate":"2002-09","conditions":"Bone Marrow Failure, Osteopetrosis, Fanconi Anemia","enrollment":38},{"nctId":"NCT01903928","phase":"PHASE2","title":"A Study to Evaluate Safety and Tolerability of a Therapeutic Vaccine, ASP0113, in Subjects Undergoing Allogeneic Hematopoietic Cell Transplant","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2013-06-20","conditions":"Allogeneic Hematopoietic Cell Transplant","enrollment":9},{"nctId":"NCT03079089","phase":"NA","title":"Sequential Conditioning in Haploidentical Transplantation for Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological Disorders","status":"COMPLETED","sponsor":"Association for Training, Education, and Research in Hematology, Immunology, and Transplantation","startDate":"2017-06-30","conditions":"Refractory or Relapsed Lymphoid Haemopathy","enrollment":40},{"nctId":"NCT06244264","phase":"NA","title":"The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis","status":"RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"2024-03-15","conditions":"Spinal Metastases, Blood Transfusion Complication, Lung Cancer","enrollment":118},{"nctId":"NCT05255445","phase":"","title":"Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients","status":"COMPLETED","sponsor":"Westat","startDate":"2022-03-16","conditions":"Sickle Cell Disease, Thalassemia, Pediatric Cancer","enrollment":157},{"nctId":"NCT06396481","phase":"EARLY_PHASE1","title":"Clinical Study of Allogeneic Vγ9Vδ2 T Cells in the Treatment of Brain Malignant Glioma","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2024-04-30","conditions":"GBM, DIPG Brain Tumor, Medulloblastoma","enrollment":25},{"nctId":"NCT06345417","phase":"","title":"Outcomes of Patient Blood Management in Severely Anemic Patients","status":"NOT_YET_RECRUITING","sponsor":"Helios Klinik Gotha/Ohrdruf","startDate":"2024-04-01","conditions":"Severe Anemia","enrollment":20000},{"nctId":"NCT06345469","phase":"","title":"Cost Analysis of Therapies for Severe Anemia","status":"NOT_YET_RECRUITING","sponsor":"Helios Klinik Gotha/Ohrdruf","startDate":"2024-04-01","conditions":"Severe Anemia","enrollment":640},{"nctId":"NCT05581238","phase":"","title":"Validation of a Red Blood Cell Transfusion Prediction Model in a Low Transfusion Rate Population.","status":"COMPLETED","sponsor":"Medisch Spectrum Twente","startDate":"2022-11-01","conditions":"Platelet Aggregation, Blood Transfusion","enrollment":6428},{"nctId":"NCT06267898","phase":"","title":"Non Interventional Study on Iron Toxicity After First Allo-transplant in MDS/CMML","status":"COMPLETED","sponsor":"European Society for Blood and Marrow Transplantation","startDate":"2009-11-01","conditions":"MDS, CMML","enrollment":222},{"nctId":"NCT05321199","phase":"NA","title":"Tranexamic Acid During Telescoping Nail Application In Osteogenesis Imperfecta","status":"COMPLETED","sponsor":"Assiut University","startDate":"2022-05-01","conditions":"Osteogenesis Imperfecta","enrollment":20},{"nctId":"NCT06103214","phase":"NA","title":"The Effects of Hemodilution Methods in Patients Undergoing Primary Debulking Gynaecological Surgery","status":"COMPLETED","sponsor":"Zhejiang Cancer Hospital","startDate":"2017-01-01","conditions":"Ovarian Neoplasm Epithelial","enrollment":144},{"nctId":"NCT05532826","phase":"NA","title":"Clinical Study of Donor EBV-CTL Infusion in Patients With CAEBV and EBV-HLH After Allo-HSCT","status":"UNKNOWN","sponsor":"Beijing Friendship Hospital","startDate":"2022-10-08","conditions":"Chronic Active Epstein-Barr Virus Infection, Virus-Associated Hemophagocytic Syndrome","enrollment":15},{"nctId":"NCT05164406","phase":"","title":"Impact of Blood Salvage Therapy on Outcomes After Oncologic Liver Surgery","status":"COMPLETED","sponsor":"Université de Sherbrooke","startDate":"2018-01-01","conditions":"Liver Neoplasms","enrollment":106},{"nctId":"NCT01264315","phase":"PHASE2","title":"Safety And Efficacy Of Lenalidomide As Maintenance Therapy In Patients With Newly Diagnosed Multiple Myeloma Following A Tandem Autologous-Allogeneic Transplant","status":"COMPLETED","sponsor":"Fondazione EMN Italy Onlus","startDate":"2008-09","conditions":"Multiple Myeloma","enrollment":53},{"nctId":"NCT05466370","phase":"","title":"Prediction of Transfusion-Associated Complications","status":"COMPLETED","sponsor":"Kepler University Hospital","startDate":"2022-07-15","conditions":"Transfusion-dependent Anemia","enrollment":3366},{"nctId":"NCT03302195","phase":"NA","title":"Optimal Cardiopulmonary Bypass and Anticoagulation Management Strategies in Obese Patients Undergoing Cardiac Surgery","status":"RECRUITING","sponsor":"Laval University","startDate":"2015-08-21","conditions":"Cardiopulmonary Bypass, Obesity","enrollment":410},{"nctId":"NCT05727917","phase":"NA","title":"Hetrombopag for the Enhancement of Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation","status":"UNKNOWN","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2023-01-01","conditions":"Hematological Disease, Allogeneic Hematopoietic Stem Cell Transplantation","enrollment":78},{"nctId":"NCT03826498","phase":"PHASE2","title":"Allogenic Cord Blood Transfusion in Patients With Cerebral Palsy","status":"UNKNOWN","sponsor":"State-Financed Health Facility \"Samara Regional Medical Center Dinasty\"","startDate":"2018-01-12","conditions":"Cerebral Palsy","enrollment":40},{"nctId":"NCT05661838","phase":"","title":"Effect of Intraoperative Allogeneic Blood Transfusion on Postoperative Pulmonary Complications","status":"COMPLETED","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2013-08-01","conditions":"Spinal Fusion, Transfusion, Pulmonary Complication","enrollment":272},{"nctId":"NCT03067155","phase":"PHASE2","title":"CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation.","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2016-10","conditions":"Hematological Malignancies, CMV Infection","enrollment":1},{"nctId":"NCT04856618","phase":"","title":"Machine Learning-Based Prediction of Major Perioperative Allogeneic Blood Requirements in Cardiac Surgery","status":"COMPLETED","sponsor":"Kepler University Hospital","startDate":"2021-06-16","conditions":"Transfusion-dependent Anemia","enrollment":3782},{"nctId":"NCT02740374","phase":"NA","title":"Evaluation of Thromboelastometry (ROTEM) During Spinal Surgery","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2015-11","conditions":"Blood Loss, Surgical","enrollment":112},{"nctId":"NCT03035422","phase":"NA","title":"Sequential Conditioning in Haploidentical Transplantation for Refractory Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"Association for Training, Education, and Research in Hematology, Immunology, and Transplantation","startDate":"2018-01-15","conditions":"Refractory Acute Myeloid Leukemia","enrollment":24},{"nctId":"NCT01773395","phase":"PHASE2","title":"GVAX vs. Placebo for MDS/AML After Allo HSCT","status":"TERMINATED","sponsor":"Dana-Farber Cancer Institute","startDate":"2013-01-08","conditions":"Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia","enrollment":123},{"nctId":"NCT04383756","phase":"EARLY_PHASE1","title":"Utilization of Donor Whole Blood for Blood Transfusion in Deceased Donor Liver Transplantation","status":"WITHDRAWN","sponsor":"Vanderbilt University Medical Center","startDate":"2020-12","conditions":"Transfusion Related Complication, Liver Transplant","enrollment":""},{"nctId":"NCT04312789","phase":"PHASE2","title":"Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant","status":"WITHDRAWN","sponsor":"Ayman Saad","startDate":"2022-12","conditions":"Platelet Disorder","enrollment":""},{"nctId":"NCT00839241","phase":"NA","title":"A Clinical Study to Investigate if Transfusion of Patients Own Shed Blood Improves the Immunological Status in Comparison to Transfusion of Donor Blood (\"Bank Blood\")","status":"COMPLETED","sponsor":"Wellspect HealthCare","startDate":"2009-01","conditions":"Arthroplasty, Replacement, Knee, Blood Transfusion, Autologous, Blood Transfusion","enrollment":45},{"nctId":"NCT02140216","phase":"","title":"Immunomodulation Effect of Blood Transfusion","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2014-05","conditions":"Incompatible Blood Transfusion, Immune Defect, Surgery","enrollment":60},{"nctId":"NCT03167788","phase":"PHASE2","title":"Red Cell Rejuvenation for the Attenuation of Transfusion Associated Organ Injury in Cardiac Surgery","status":"WITHDRAWN","sponsor":"University of Leicester","startDate":"2020-12","conditions":"Organ Failure, Multiple, Inflammation, Sepsis","enrollment":""},{"nctId":"NCT02075970","phase":"PHASE2","title":"Optimized Erythropoietin (EPO) Treatment","status":"COMPLETED","sponsor":"John A Widness","startDate":"2014-06","conditions":"Neonatal Anemia","enrollment":62},{"nctId":"NCT04514575","phase":"","title":"Plasma Transfusion in Major Vascular Surgery","status":"COMPLETED","sponsor":"Naestved Hospital","startDate":"1997-01-01","conditions":"Aortic Aneurysm, Abdominal, Arterial Occlusive Diseases","enrollment":17000},{"nctId":"NCT03786744","phase":"PHASE1, PHASE2","title":"Allogenic Cord Blood Transfusion in Patients With Autism","status":"COMPLETED","sponsor":"State-Financed Health Facility \"Samara Regional Medical Center Dinasty\"","startDate":"2018-10-12","conditions":"Autism Spectrum Disorder, Autism","enrollment":20},{"nctId":"NCT04599426","phase":"PHASE1, PHASE2","title":"Allogenic NK Cell Transfusion Azacitidine MDS-EB","status":"UNKNOWN","sponsor":"The Second Hospital of Shandong University","startDate":"2020-12-01","conditions":"MDS-EB","enrollment":10},{"nctId":"NCT03391856","phase":"PHASE2, PHASE3","title":"Prolonged Isolated Thrombocytopenia After Allo-SCT : N-acetyl-L-cysteine (NAC) Versus Supportive Therapy","status":"TERMINATED","sponsor":"Peking University People's Hospital","startDate":"2018-03-01","conditions":"Thrombocytopenia, Stem Cell Transplant Complications","enrollment":15},{"nctId":"NCT02857920","phase":"PHASE1, PHASE2","title":"Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid Tumors","status":"COMPLETED","sponsor":"Fuda Cancer Hospital, Guangzhou","startDate":"2016-08-01","conditions":"Malignant Solid Tumour","enrollment":45},{"nctId":"NCT02747615","phase":"PHASE4","title":"Efficacy of Preoperative Autologous Blood Donation and Tranexamic Acid in Revision Total Hip Arthroplasty","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2010-08","conditions":"Revision Total Hip Arthroplasty (RTHA)","enrollment":60},{"nctId":"NCT03548766","phase":"PHASE3","title":"Using DNA-Typing and Erythrocyte Microparticle Analysis to Detect Blood Doping","status":"UNKNOWN","sponsor":"Hamad Medical Corporation","startDate":"2018-09-20","conditions":"Blood Disease, Blood Transfusion, Autologous, Blood Doping","enrollment":12},{"nctId":"NCT00578344","phase":"NA","title":"Bone Marrow Transplantation, Hemoglobinopathies, SCALLOP","status":"TERMINATED","sponsor":"Tami D. John","startDate":"2005-07","conditions":"Sickle Cell Disease, Hemoglobin SC","enrollment":8},{"nctId":"NCT01490723","phase":"PHASE2","title":"Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2013-01","conditions":"Leukemia, Lymphoma","enrollment":20},{"nctId":"NCT00578292","phase":"NA","title":"Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO","status":"TERMINATED","sponsor":"Baylor College of Medicine","startDate":"2004-02","conditions":"Thalassemia","enrollment":10},{"nctId":"NCT04331405","phase":"PHASE1, PHASE2","title":"Allogeneic Cord Blood Cells for Adults With Severe Acute Contusion Spinal Cord Injury","status":"COMPLETED","sponsor":"Sklifosovsky Institute of Emergency Care","startDate":"2013-03-18","conditions":"Spinal Cord Contusion","enrollment":20},{"nctId":"NCT03183479","phase":"PHASE4","title":"The Effects of Fibrinogen Concentrate Infusion on Blood Loss and Allogeneic Blood Conservation in Scoliosis Surgery","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2017-06-14","conditions":"Scoliosis; Adolescence, Bleeding, Surgery","enrollment":102},{"nctId":"NCT00176852","phase":"PHASE2, PHASE3","title":"Stem Cell Transplant for Hemoglobinopathy","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2002-06","conditions":"Sickle Cell Disease, Thalassemia, Severe Congenital Neutropenia","enrollment":22},{"nctId":"NCT04061655","phase":"EARLY_PHASE1","title":"Effect of Intravenous Iron Supplementation in Reducing Allogenic Blood Transfusion","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2019-09-20","conditions":"Complications","enrollment":80},{"nctId":"NCT03339700","phase":"PHASE2","title":"Addition of Gemcitabine to Pre Allo-HSCT Conditioning for Acute Lymphoblastic Leukemia","status":"UNKNOWN","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2018-09-15","conditions":"Acute Lymphoblastic Leukemia, Adult","enrollment":15},{"nctId":"NCT02605460","phase":"PHASE2","title":"Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission","status":"UNKNOWN","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2014-02","conditions":"Acute Myeloid Leukemia, Acute Lymphoid Leukemia","enrollment":20},{"nctId":"NCT04046705","phase":"PHASE3","title":"Comparison of Allogeneic Matched Related Haematopoietic Stem Cell Transplantation After a Reduced Intensity Conditioning Regimen With Standard of Care in Adolescents and Adults With Severe Sickle Cell Disease","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-10-15","conditions":"Sickle Cell Disease","enrollment":78},{"nctId":"NCT02853903","phase":"PHASE2","title":"Comparison of Autogenic and Allogenic NK Immunotherapy on the Outcome of Recurrent Solid Tumors","status":"COMPLETED","sponsor":"Fuda Cancer Hospital, Guangzhou","startDate":"2016-07-01","conditions":"Malignant Solid Tumour","enrollment":20},{"nctId":"NCT01442051","phase":"NA","title":"Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2011-09-23","conditions":"Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma","enrollment":52},{"nctId":"NCT02648516","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Allogenic Adoptive Immune Therapy for Immune Reconstitution in Chronic HIV-1 Infected Patients","status":"UNKNOWN","sponsor":"Beijing 302 Hospital","startDate":"2016-10","conditions":"Human Immunodeficiency Virus, Disorder of Immune Reconstitution","enrollment":20},{"nctId":"NCT03891303","phase":"","title":"Allogenic Blood Transfusion During Elective Open Abdominal Aortic Surgery","status":"COMPLETED","sponsor":"Clinic for Cardiovascular Diseases Magdalena","startDate":"2011-01-01","conditions":"Blood Transfusion","enrollment":426},{"nctId":"NCT01980030","phase":"PHASE1, PHASE2","title":"Using ROMIPLOSTINE for Persistent Thrombocytopenia With Transfusion-dependent Patients Who Received Allogeneic Hematopoietic Stem Cell","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2013-11","conditions":"Persistent Thrombocytopenia Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)","enrollment":24},{"nctId":"NCT01060176","phase":"NA","title":"Three Dose Regimen of Tranexamic Acid in Cardiac Surgery","status":"UNKNOWN","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2010-02","conditions":"Hemostasis","enrollment":600},{"nctId":"NCT03756948","phase":"NA","title":"Viscoelastic Tests-Guided Therapy In Liver Transplantation","status":"COMPLETED","sponsor":"Hospital Israelita Albert Einstein","startDate":"2007-01-01","conditions":"Liver Transplant; Complications, Bleeding, Hemostatic Disorder","enrollment":237},{"nctId":"NCT02902939","phase":"NA","title":"Myeloid-Derived Supressor Cells in Cardiac Surgery Patients","status":"COMPLETED","sponsor":"Research Institute for Complex Problems of Cardiovascular Diseases, Russia","startDate":"2016-09","conditions":"Insufficiency; Cardiac, Complicating Surgery, Systemic Inflammatory Response Syndrome","enrollment":100},{"nctId":"NCT03482128","phase":"","title":"Blood Transfusion and Postoperative Outcome Before and After Implementing a Coagulation Management Algorithm","status":"COMPLETED","sponsor":"Triemli Hospital","startDate":"2011-01-01","conditions":"Coagulation Disorder, Blood","enrollment":1754},{"nctId":"NCT02058134","phase":"NA","title":"The CardioPAT Project: A Randomized Trial","status":"TERMINATED","sponsor":"Rigshospitalet, Denmark","startDate":"2013-12","conditions":"Coronary Artery Disease, Aortic Stenosis, Aortic Insufficiency","enrollment":68},{"nctId":"NCT03246178","phase":"NA","title":"Haploidentical Transplantation in Severe Aplastic Anemia","status":"UNKNOWN","sponsor":"Wu Xiaoxiong","startDate":"2017-07-10","conditions":"Severe Aplastic Anemia","enrollment":60},{"nctId":"NCT02981199","phase":"NA","title":"Microtransplantation Versus Auto-SCT in ≥PR Multiple Myeloma Patients","status":"UNKNOWN","sponsor":"Chen Wenming","startDate":"2016-01","conditions":"Microtransplantation, Autologous Stem Cell Transplantation, Multiple Myeloma in Relapse","enrollment":80},{"nctId":"NCT01340404","phase":"NA","title":"Allogeneic Genoidentical Stem Cell Transplantation in Children With Sickle-cell Anemia and Cerebral Vasculopathy","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2010-12","conditions":"Sickle Cell Anemia, Cerebrovascular Accident","enrollment":63},{"nctId":"NCT02601131","phase":"","title":"Post-transfusion Platelet Count","status":"COMPLETED","sponsor":"Region Skane","startDate":"2016-02","conditions":"Leukemia, Multiple Sclerosis","enrollment":80},{"nctId":"NCT00654589","phase":"PHASE4","title":"Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2008-02","conditions":"Iron Overload","enrollment":75},{"nctId":"NCT02513862","phase":"NA","title":"Prospective Trial of Autologous Platelet Rich Plasma in Aortic Surgery","status":"COMPLETED","sponsor":"Hongwen Ji","startDate":"2015-05","conditions":"C.Surgical Procedure; Cardiac","enrollment":80},{"nctId":"NCT00849745","phase":"PHASE1","title":"Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases","status":"TERMINATED","sponsor":"Duke University","startDate":"2003-01","conditions":"Systemic Lupus Erythematosus, Systemic Sclerosis","enrollment":4}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":705,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Allogeneic transfusion","genericName":"Allogeneic transfusion","companyName":"Helios Klinik Gotha/Ohrdruf","companyId":"helios-klinik-gotha-ohrdruf","modality":"Biologic","firstApprovalDate":"","aiSummary":"Allogeneic transfusion involves the transfer of blood components from a donor to a recipient to replace or supplement the recipient's blood supply. Used for Treatment of anemia in patients with chronic kidney disease, Treatment of bleeding disorders, such as hemophilia A and B.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}